Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107852
Filing Date
2025-11-06
Accepted
2025-11-06 17:12:12
Documents
83
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20250930x10q.htm   iXBRL 10-Q 2723660
2 EX-31.1 chrs-20250930xex31d1.htm EX-31.1 13968
3 EX-31.2 chrs-20250930xex31d2.htm EX-31.2 14861
4 EX-32.1 chrs-20250930xex32d1.htm EX-32.1 11967
  Complete submission text file 0001104659-25-107852.txt   11015955

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20250930.xsd EX-101.SCH 69189
6 EX-101.CAL chrs-20250930_cal.xml EX-101.CAL 85318
7 EX-101.DEF chrs-20250930_def.xml EX-101.DEF 326399
8 EX-101.LAB chrs-20250930_lab.xml EX-101.LAB 563939
9 EX-101.PRE chrs-20250930_pre.xml EX-101.PRE 468468
86 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250930x10q_htm.xml XML 2066374
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 251459525
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)